Japan Vietnam Medical Investment and Development Joint Stock Company (HOSE: JVC)
Health Care · Health Care Providers & Services · VN
₫2,890.00
+12.02% today · -66.8% 1Y
Japan Vietnam Medical Investment and Development Joint Stock Company (HOSE: JVC) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $12.56M.
Over the last twelve months the share price has lost 66.8%, trading between 2.40K and 8.83K.
Tweenvest scores Japan Vietnam Medical Investment and Development Joint Stock Company across four factors: quality 63/100, value 69/100, growth 0/100. Its strongest factor is value.
JVC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.56M
- Revenue (TTM)
- $28.39M
- P/E
- 6.44
- EPS
- 448.90
- Dividend yield
- —
- Beta (5Y)
- 0.83
- 52-week high
- ₫8,830.00
- 52-week low
- ₫2,400.00
- Avg volume (3M)
- —
- Shares outstanding
- 112.50M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Topvision Eye Specialist BerhadKLSE: TOPVISN | $12.89M | RM0.17 | +3.03% |
| Sinopharm Tech Holdings LimitedSEHK: 8156 | $12.84M | HK$0.16 | +1.27% |
| Balaxi Pharmaceuticals LimitedNSEI: BALAXI | $12.74M | Rs22.33 | -0.04% |
| MedNation AGDB: EIF | $12.58M | €4.00 | -0.50% |
| New Century Healthcare Holding Co. LimitedSEHK: 1518 | $12.31M | HK$0.20 | +7.53% |
| Abate AS Industries LimitedBSE: 531658 | $12.30M | Rs7.55 | -5.39% |
| Speed Medical CoCASE: SPMD | $12.23M | EGP0.39 | -4.70% |
| Aspira Pathlab & Diagnostics LimitedBSE: 540788 | $12.23M | Rs115.00 | -12.38% |
Figures last refreshed Oct 11, 2026.